These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21489910)

  • 1. Plasma osteopontin levels in patients with Behcet's disease and psoriasis.
    Erturkler E; Cıcek D; Kaman D; Ozdogan S; Bakar Dertlıoglu S
    Eur J Dermatol; 2011; 21(2):203-8. PubMed ID: 21489910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma thrombomodulin levels in patients with Behçet's disease.
    Düzgün N; Ayaşlioğlu E; Tutkak H; Sahin M; Aydintuğ O; Olmez U
    Rheumatol Int; 2003 May; 23(3):130-3. PubMed ID: 12739044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
    Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
    Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
    Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
    Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin levels in Behçet's disease.
    Kandi B; Cicek D; Ilhan N
    J Dermatolog Treat; 2007; 18(2):69-75. PubMed ID: 17520462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
    Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
    Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased erythrocyte deformability in Behçet's disease.
    Usküdar O; Erdem A; Demiroğlu H; Dikmenoğlu N
    Clin Hemorheol Microcirc; 2005; 33(2):89-94. PubMed ID: 16151256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
    Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
    Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular involvement in Behçet's disease.
    Peplinski LS
    J Am Optom Assoc; 1989 Nov; 60(11):854-7. PubMed ID: 2607080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Bcl-2 in inflammatory sites from patients with active Behçet's disease.
    Hamzaoui K; Hamzaoui A; Zakraoui L; Chabbou A
    Mediators Inflamm; 1999; 8(2):101-6. PubMed ID: 10704147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)].
    Kagawa H; Okubo S
    Ryumachi; 1993 Oct; 33(5):416-23. PubMed ID: 8256164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of Budd-Chiari syndrome induced by Behcet's disease.
    Kuniyoshi Y; Koja K; Miyagi K; Uezu T; Yamashiro S; Arakaki K; Mabuni K; Senaha S
    Ann Thorac Cardiovasc Surg; 2002 Dec; 8(6):374-80. PubMed ID: 12517299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase-9 expression is increased in endothelial cells of active Behçet's disease patients.
    Oztaş P; Lortlar N; Polat M; Alli N; Omeroğlu S; Basman A
    Int J Dermatol; 2007 Feb; 46(2):172-6. PubMed ID: 17269970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budd-Chiari syndrome: a common complication of Behçet's disease.
    Bayraktar Y; Balkanci F; Bayraktar M; Calguneri M
    Am J Gastroenterol; 1997 May; 92(5):858-62. PubMed ID: 9149201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Preptin and Amylin Values in Psoriasis Vulgaris and Behçet's Patients.
    Dogan FB; Cicek D; Aydin S; Dertlioglu SB; Halisdemir N; Ucak H; Demir B; Erden I
    J Clin Lab Anal; 2016 Mar; 30(2):165-8. PubMed ID: 25545917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated protein C levels in Behçet's disease and risk of venous thrombosis.
    Navarro S; Ricart JM; Medina P; Vayá A; Villa P; Todolí J; Estellés A; Micó ML; Aznar J; España F
    Br J Haematol; 2004 Aug; 126(4):550-6. PubMed ID: 15287949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of serum lipocalin-2 and retinol binding protein-4 levels in patients with psoriasis and Behçet's disease.
    Gul FC; Cicek D; Kaman D; Demir B; Nazik H
    Eur J Dermatol; 2015 Apr; 25(2):195-7. PubMed ID: 25547333
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevated oxidative stress markers and its relationship with endothelial dysfunction in Behçet disease.
    Acikgoz N; Ermiş N; Yağmur J; Cansel M; Karincaoğlu Y; Ataş H; Cuglan B; Barutcu I; Pekdemir H; Özdemir R
    Angiology; 2011 May; 62(4):296-300. PubMed ID: 20947865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble levels of osteopontin in patients with Behcet's disease: association with disease activity and vascular involvement.
    Bassyouni IH; El-Wakd MM; Bassyouni RH
    J Clin Immunol; 2013 Feb; 33(2):361-7. PubMed ID: 23097037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.